The prognostic significance of MIR100HG expression has been investigated in breast cancer [22], bladder cancer [1], cervical cancer [16], osteosarcoma [18], and head and neck squamous cell carcinoma [24]. This evidence concerns the gene MIR100HG and urinary bladder carcinoma.